Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2491
    -0.0020 (-0.16%)
     

  • Bitcoin GBP

    51,071.12
    -654.75 (-1.27%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.96%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

SARTORIUS AG (SARTF) Surges 3.7%: Is This an Indication of Further Gains?

Zacks Equity Research
·2-min read

SARTORIUS AG (SARTF) shares soared 3.7% in the last trading session to close at $745. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 8.5% loss over the past four weeks.

The stock scored a strong price increase on the optimism surrounding the company’s recent update regarding the expansion of its business operations in Michigan, North America. The new facility will combine existing business operations in Washtenaw County to develop a center of excellence in Ann Arbor for the Laboratory and Bioprocess Products and Services in North America. Further, a raised full-year 2021 guidance, projecting consolidated sales growth of around 48% (up from earlier guided 38%) boosts investors’ confidence.

This company is expected to post quarterly earnings of $2.37 per share in its upcoming report, which represents a year-over-year change of +59.1%. Revenues are expected to be $1.01 billion, up 38.1% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

ADVERTISEMENT

For SARTORIUS AG, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SARTF going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SARTORIUS AG (SARTF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research